Aspirin Potentially Treat Osteoporosis
Osteoporosis - Who is not familiar with aspirin or acetylsalicylic acid (asetosal). This one drug has been known since hundreds of years ago and often used as an analgesic (pain or minor aches), antipyretic (drug fever), and anti-inflammatory or inflammation.
In addition to nutritious treat various symptoms and disease, the benefits of aspirin has also been growing along with the incessant research experts. Recent research on animals, for example, the potential ability of aspirin to treat bone loss or osteoporosis.
In a study published in the journal PLoS One, researchers from the United States indicate that low-dose aspirin can reduce the activity of cells that gnaw the bone. On the other hand, aspirin also can increase the activity of the cells that build bone density.
By experts, the increased activity of cells that destroy bone density is typically referred to as the cause of osteoporosis. However, according to Dr. Songtao Shi from the University of Southern California School of Dentistry, Los Angeles, recent evidence has indicated that the decrease in the number of cells that form bone diseases also contribute to the occurrence of bone loss.
In his research, a team led by Dr. Songtao Shi proved that aspirin can reduce the level of damage to cells that form bone in mice. They also can show further that by adding low-dose aspirin, bone-forming cells become more active, whereas cells that destroy bone became less active. With the addition of aspirin, these rat bones become stronger and more solid.
"Aspirin may be able to offer a new approach to treat osteoporosis that many experienced by women after menopause," researchers said as quoted Reutershealth, Thursday (31/7).
Although some research in humans has indicated that the use of aspirin on a regular basis to provide sufficient benefits in postmenopausal women bone compaction, Shi stressed the importance of continued research to uncover more detail and clarify the mechanism of aspirin in preventing and treating osteoporosis.